Literature DB >> 27683847

Cognitive reserve in frontotemporal degeneration: Neuroanatomic and neuropsychological evidence.

Katerina Placek1, Lauren Massimo1, Christopher Olm1, Kylie Ternes1, Kim Firn1, Vivianna Van Deerlin1, Edward B Lee1, John Q Trojanowski1, Virginia M-Y Lee1, David Irwin1, Murray Grossman1, Corey T McMillan2.   

Abstract

OBJECTIVE: To evaluate if cognitive reserve (CR) contributes to interindividual differences in frontal gray matter density (GMD) and executive impairment that underlie heterogeneity in the disease course of confirmed frontotemporal lobar degeneration (FTLD) pathology.
METHODS: Fifty-five patients with autopsy confirmation or a pathogenic mutation consistent with underlying tau (FTLD-tau) or TDP-43 (FTLD-TDP) pathology and 90 demographically comparable healthy controls were assessed with T1 MRI and neuropsychological measures (Mini-Mental State Examination, letter fluency, forward digit span, Rey complex figure, and Boston Naming Test). CR was indexed using a composite measure of education and occupation. We used t tests to identify reduced GMD in patients with FTLD relative to controls, regression analyses to relate reduced GMD to CR index, and correlations to relate regions of GMD associated with CR to performance on neuropsychological measures.
RESULTS: Patients with FTLD demonstrated impairment on neuropsychological measures. Patients with FTLD exhibited reduced bilateral frontotemporal GMD relative to controls, consistent with the known anatomic distribution of FTLD pathology. Higher CR index was associated with superior letter fluency and with GMD in right dorsolateral prefrontal cortex, orbitofrontal cortex, rostral frontal cortex, and inferior frontal gyrus. Furthermore, we found that higher GMD in frontal regions associated with CR was associated with superior letter fluency.
CONCLUSIONS: Executive control and verbal ability assessed by letter fluency in FTLD is mediated in part by CR and frontal GMD. The identification of factors influencing cognitive and anatomic heterogeneity in FTLD suggests that CR should be considered in symptom detection, prognosis, and treatment.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27683847      PMCID: PMC5089523          DOI: 10.1212/WNL.0000000000003250

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

2.  Relationship between occupation attributes and brain metabolism in frontotemporal dementia.

Authors:  R Nathan Spreng; Alexander Drzezga; Janine Diehl-Schmid; Alexander Kurz; Brian Levine; Robert Perneczky
Journal:  Neuropsychologia       Date:  2011-09-21       Impact factor: 3.139

3.  Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration.

Authors:  Lauren Massimo; Jarcy Zee; Sharon X Xie; Corey T McMillan; Katya Rascovsky; David J Irwin; Ann Kolanowski; Murray Grossman
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

4.  Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease.

Authors:  Beatriz Bosch; David Bartrés-Faz; Lorena Rami; Eider M Arenaza-Urquijo; Davinia Fernández-Espejo; Carme Junqué; Cristina Solé-Padullés; Raquel Sánchez-Valle; Núria Bargalló; Carles Falcón; José Luis Molinuevo
Journal:  Cortex       Date:  2009-05-20       Impact factor: 4.027

5.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

6.  Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

Authors:  Julene K Johnson; Janine Diehl; Mario F Mendez; John Neuhaus; Jill S Shapira; Mark Forman; Dennis J Chute; Erik D Roberson; Catherine Pace-Savitsky; Manuela Neumann; Tiffany W Chow; Howard J Rosen; Hans Forstl; Alexander Kurz; Bruce L Miller
Journal:  Arch Neurol       Date:  2005-06

7.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

8.  Narrative discourse deficits in amyotrophic lateral sclerosis.

Authors:  Sharon Ash; Anna Menaged; Christopher Olm; Corey T McMillan; Ashley Boller; David J Irwin; Leo McCluskey; Lauren Elman; Murray Grossman
Journal:  Neurology       Date:  2014-07-02       Impact factor: 9.910

9.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Authors:  Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz
Journal:  Amyotroph Lateral Scler       Date:  2009-06

10.  TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

Authors:  Michael D Gallagher; Eunran Suh; Murray Grossman; Lauren Elman; Leo McCluskey; John C Van Swieten; Safa Al-Sarraj; Manuela Neumann; Ellen Gelpi; Bernardino Ghetti; Jonathan D Rohrer; Glenda Halliday; Christine Van Broeckhoven; Danielle Seilhean; Pamela J Shaw; Matthew P Frosch; Irina Alafuzoff; Anna Antonell; Nenad Bogdanovic; William Brooks; Nigel J Cairns; Johnathan Cooper-Knock; Carl Cotman; Patrick Cras; Marc Cruts; Peter P De Deyn; Charles DeCarli; Carol Dobson-Stone; Sebastiaan Engelborghs; Nick Fox; Douglas Galasko; Marla Gearing; Ilse Gijselinck; Jordan Grafman; Päivi Hartikainen; Kimmo J Hatanpaa; J Robin Highley; John Hodges; Christine Hulette; Paul G Ince; Lee-Way Jin; Janine Kirby; Julia Kofler; Jillian Kril; John B J Kwok; Allan Levey; Andrew Lieberman; Albert Llado; Jean-Jacques Martin; Eliezer Masliah; Christopher J McDermott; Ann McKee; Catriona McLean; Simon Mead; Carol A Miller; Josh Miller; David G Munoz; Jill Murrell; Henry Paulson; Olivier Piguet; Martin Rossor; Raquel Sanchez-Valle; Mary Sano; Julie Schneider; Lisa C Silbert; Salvatore Spina; Julie van der Zee; Tim Van Langenhove; Jason Warren; Stephen B Wharton; Charles L White; Randall L Woltjer; John Q Trojanowski; Virginia M Y Lee; Vivianna Van Deerlin; Alice S Chen-Plotkin
Journal:  Acta Neuropathol       Date:  2014-01-19       Impact factor: 17.088

View more
  9 in total

1.  Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.

Authors:  David J Irwin; Corey T McMillan; Sharon X Xie; Katya Rascovsky; Vivianna M Van Deerlin; H Branch Coslett; Roy Hamilton; Geoffrey K Aguirre; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Murray Grossman
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

2.  Mendelian and Sporadic FTD: Disease Risk and Avenues from Genetics to Disease Pathways Through In Silico Modelling.

Authors:  Claudia Manzoni; Raffaele Ferrari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Cognitive impairment across ALS clinical stages in a population-based cohort.

Authors:  Adriano Chiò; Cristina Moglia; Antonio Canosa; Umberto Manera; Rosario Vasta; Maura Brunetti; Marco Barberis; Lucia Corrado; Sandra D'Alfonso; Enrica Bersano; Maria Francesca Sarnelli; Valentina Solara; Jean Pierre Zucchetti; Laura Peotta; Barbara Iazzolino; Letizia Mazzini; Gabriele Mora; Andrea Calvo
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

4.  Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

Authors:  Corey T McMillan; Joanne Wuu; Katya Rascovsky; Stephanie Cosentino; Murray Grossman; Lauren Elman; Colin Quinn; Luis Rosario; Jessica H Stark; Volkan Granit; Hannah Briemberg; Sneha Chenji; Annie Dionne; Angela Genge; Wendy Johnston; Lawrence Korngut; Christen Shoesmith; Lorne Zinman; Sanjay Kalra; Michael Benatar
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-03-07       Impact factor: 3.528

5.  UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis.

Authors:  Katerina Placek; G Michael Baer; Lauren Elman; Leo McCluskey; Laura Hennessy; Pilar M Ferraro; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman; David J Irwin; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-09-27       Impact factor: 4.673

6.  Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.

Authors:  Christopher A Olm; Corey T McMillan; David J Irwin; Vivianna M Van Deerlin; Philip A Cook; James C Gee; Murray Grossman
Journal:  Neuroimage Clin       Date:  2018-05-15       Impact factor: 4.881

7.  Behavioral Reserve in Behavioral Variant Frontotemporal Dementia.

Authors:  Su Hong Kim; Yae Ji Kim; Byung Hwa Lee; Peter Lee; Ji Hyung Park; Sang Won Seo; Yong Jeong
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

8.  High occurrence of transportation and logistics occupations among vascular dementia patients: an observational study.

Authors:  A C van Loenhoud; C de Boer; K Wols; Y A Pijnenburg; A W Lemstra; F H Bouwman; N D Prins; P Scheltens; R Ossenkoppele; W M van der Flier
Journal:  Alzheimers Res Ther       Date:  2019-12-27       Impact factor: 6.982

Review 9.  Effects of Cognitive Reserve on Cognition in Individuals With Central Nervous System Disease.

Authors:  Varna R Jammula; Heather Leeper; Mark R Gilbert; Diane Cooper; Terri S Armstrong
Journal:  Cogn Behav Neurol       Date:  2021-12-02       Impact factor: 1.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.